Clinical Trials Browser

Withdrawn × NETWORK × Ramucirumab × Clear all

NCT04267913 2020-11-20

Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)

Phase 2 Withdrawn

Lung Neoplasms

NCT03766607 2019-09-19

Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer

Phase 2 Withdrawn

Gastrointestinal

Stomach Neoplasms